Your browser does not support scripts, this page will not display properly!
ISMP (US)
Contact Us
Feedback
Search:
ISMP Canada News
March 16, 2018:
Health Canada: Zinbryta (daclizumab beta) - Voluntary Withdrawal in Canada due to Risk of Encephalitis
Health Canada: Zinbryta (daclizumab beta) - Voluntary Withdrawal in Canada due to Risk of Encephalitis" trackback:ping="https://www.ismp-canada.org/news/bblog/trackback.php/325/" />
Copyright © 2000-2016 Institute for Safe Medication Practices Canada (ISMP Canada). All Rights Reserved.